Optimized Strategy for in Vivo Cas9-activation in Drosophila

Ben Ewen-Campen,Donghui Yang-Zhou,Vitória R Fernandes,Delfina P González,Lu-Ping Liu,Rong Tao,Xingjie Ren,Jin Sun,Yanhui Hu,Jonathan Zirin,Stephanie E Mohr,Jian-Quan Ni,Norbert Perrimon
DOI: https://doi.org/10.1073/pnas.1707635114
2017-01-01
Abstract:While several large-scale resources are available for in vivo loss-of-function studies in Drosophila, an analogous resource for overexpressing genes from their endogenous loci does not exist. We describe a strategy for generating such a resource using Cas9 transcriptional activators (CRISPRa). First, we compare a panel of CRISPRa approaches and demonstrate that, for in vivo studies, dCas9-VPR is the most optimal activator. Next, we demonstrate that this approach is scalable and has a high success rate, as >75% of the lines tested activate their target gene. We show that CRISPRa leads to physiologically relevant levels of target gene expression capable of generating strong gain-of-function (GOF) phenotypes in multiple tissues and thus serves as a useful platform for genetic screening. Based on the success of this CRISRPa approach, we are generating a genome-wide collection of flies expressing single-guide RNAs (sgRNAs) for CRISPRa. We also present a collection of more than 30 Gal4 > UAS:dCas9-VPR lines to aid in using these sgRNA lines for GOF studies in vivo.
What problem does this paper attempt to address?